Nexus AG

XETRA NXU.DE

Nexus AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2023: USD -18.46 M

Nexus AG Net Cash Used Provided By Financing Activities is USD -18.46 M for the year ending December 31, 2023, a -129.76% change year over year. Net cash used/provided by financing activities are the total cash inflows and outflows related to activities that finance the company’s operations, including debt, equity, and dividends.
  • Nexus AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2022 was USD 62.02 M, a 591.57% change year over year.
  • Nexus AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2021 was USD -12.62 M, a 36.02% change year over year.
  • Nexus AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2020 was USD -19.72 M, a -73.12% change year over year.
  • Nexus AG Net Cash Used Provided By Financing Activities for the year ending December 31, 2019 was USD -11.39 M, a -248.12% change year over year.
Key data
Date Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure Effect Of Forex Changes On Cash
Market news
Loading...
SV Wall Street
XETRA: NXU.DE

Nexus AG

Description

Nexus AG develops and sells software and hardware solutions, and provides IT services, primarily for customers in the health care system worldwide. It operates in two divisions, Healthcare Software and Healthcare Services. The company offers information systems, such as NEXUS/HIS and KIS for somatic hospitals; NEXUS/PSYCHIATRY for psychiatric institutions; NEXUS/REHAB for rehabilitation facilities; ITR, a software for rehabilitation, clinics, and hotels with medical care; NEXUS/ARCHIVE and PEGASOS, an archiving and process management system; NEXUS/QM for quality management; NEXUS/INTEGRATION SERVER, an interface management; NEXUS/CLOUD IT, outsourcing solution; NEXUS/EPS, a software solution to supplement SAP personnel management, as well as process and HR consulting in the SAP environment; ifa systems, an ophthalmology software solution; Sophrona solutions, ophthalmology patients and referral program; and NEXUS/DIS, interdisciplinary diagnostic information system. Its information systems also comprise NEXUS/SWISSLAB, a laboratory information system; NEXUS/LAURIS for order communication in diagnostics; NEXUS/PATHOLOGY and NEXUS/CYTOLOGY for pathology and cytology institutes; dc-Pathos and dc-LabMan for pathology and cytology devices; NEXUS/RADIOLOGY, an information and image system for radiology wards and offices; NEXUs/CHILI, for PACS and teleradiology solutions; NEXUS/ASTRAIA for obstetrics and gynecology; NEXUS/SPECIAL DIAGNOSTICS and Clinic WinData for medical specialist diagnostics and device integration; NEXUS/HOME for senior citizen and nursing homes; NEXUS/OUTPATIENT CARE and Asebis, a homecare solution; NEXUS/PAT, an administration system for hospitals; and osoTEC for billing personal and other services. In addition, the company offers SINAPSI, highsystemNET, CREATIV OM, SEXTANT, Emed, NEXUS/EPD, NEXUS/AEMP, NEXUS/SPM, EuroSDS, RVS Software, NEXUS/VITA and TESIS VITA, and NEXUS/ESKULAP. NEXUS AG is headquartered in Donaueschingen, Germany.

Similar companies

AOF.DE

ATOSS Software AG

USD 122.90

2.66%

COP.DE

CompuGroup Medical SE & Co. KGaA

USD 23.47

-1.90%

MUM.DE

Mensch und Maschine Software SE

USD 53.01

-1.56%

COK.DE

Cancom SE

USD 25.55

-2.57%

IVU.DE

IVU Traffic Technologies AG

USD 16.11

-0.60%

StockViz Staff

February 6, 2025

Any question? Send us an email